Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 2:03 PM UTC
| NCT Number | NCT07518186 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE3 |
| Target Enrollment | 700 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Janssen Research & Development, LLC |
| Last Updated on CT.gov | July 31, 2026 (3 weeks ago) |
As of August 27, 2026: Clinical trial NCT07518186 is currently recruiting participants. This phase3 study for multiple myeloma is actively seeking new participants at 26 locations across the United States. The study is sponsored by Janssen Research & Development, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07518186 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07518186 was last updated 3 weeks ago (July 31, 2026). HelloStudys verifies this status automatically.